Evidence map›Paper›PMID 23617267›Full record

ArticleBMC medical informatics and decision making2013

Mining FDA drug labels for medical conditions.

Qi Li, Louise Deleger, Todd Lingren, Haijun Zhai, Megan Kaiser, Laura Stoutenborough, Anil G Jegga, Kevin Bretonnel Cohen, Imre Solti

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Neural Multi-Task Learning for Adverse Drug Reaction Extraction.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2020
    Article
  5. Exploring Novel Computable Knowledge in Structured Drug Product Labels.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Exploring Spanish health social media for detecting drug effects.BMC medical informatics and decision making · 2015
    Article
  12. Automatic extraction of drug indications from FDA drug labels.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qi LiDivision of Biomedical Informatics, Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA.
Louise Deleger
Todd Lingren
Haijun Zhai
Megan Kaiser
Laura Stoutenborough
Anil G Jegga
Kevin Bretonnel Cohen
Imre Solti

Funding

Bio Text NLPR01LM009254 · NLM · UNIVERSITY OF COLORADO DENVER · PI HUNTER, LAWRENCE E · 2006 to 2018
$5.9M
Better Outcomes for Children: GWAS & PheWAS in eMERGEII.U01HG006828 · NHGRI · CINCINNATI CHILDRENS HOSP MED CTR · PI HARLEY, JOHN BARKER, HOLM, INGRID ADELE · 2012 to 2014
$4.0M
Increasing Clinical Trial Enrollment: A Semi-Automated Patient Centered ApproachR00LM010227 · NLM · CINCINNATI CHILDRENS HOSP MED CTR · PI SOLTI, IMRE · 2010 to 2012
$727k
EHR-based patient safety: Automated error detection in neonatal intensive careR21HD072883 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI SOLTI, IMRE · 2012 to 2013
$407k
NHGRI NIH HHS 1U01HG006828-01NICHD NIH HHS 1R21HD072883-01NLM NIH HHS 5R00LM010227-04NLM NIH HHS R01 LM009254
6 · The paper itself

Abstract

backgroundCincinnati Children's Hospital Medical Center (CCHMC) has built the initial Natural Language Processing (NLP) component to extract medications with their corresponding medical conditions (Indications, Contraindications, Overdosage, and Adverse Reactions) as triples of medication-related information ([(1) drug name]-[(2) medical condition]-[(3) LOINC section header]) for an intelligent database system, in order to improve patient safety and the quality of health care. The Food and Drug Administration's (FDA) drug labels are used to demonstrate the feasibility of building the triples as an intelligent database system task.

methodsThis paper discusses a hybrid NLP system, called AutoMCExtractor, to collect medical conditions (including disease/disorder and sign/symptom) from drug labels published by the FDA. Altogether, 6,611 medical conditions in a manually-annotated gold standard were used for the system evaluation. The pre-processing step extracted the plain text from XML file and detected eight related LOINC sections (e.g. Adverse Reactions, Warnings and Precautions) for medical condition extraction. Conditional Random Fields (CRF) classifiers, trained on token, linguistic, and semantic features, were then used for medical condition extraction. Lastly, dictionary-based post-processing corrected boundary-detection errors of the CRF step. We evaluated the AutoMCExtractor on manually-annotated FDA drug labels and report the results on both token and span levels.

resultsPrecision, recall, and F-measure were 0.90, 0.81, and 0.85, respectively, for the span level exact match; for the token-level evaluation, precision, recall, and F-measure were 0.92, 0.73, and 0.82, respectively.

conclusionsThe results demonstrate that (1) medical conditions can be extracted from FDA drug labels with high performance; and (2) it is feasible to develop a framework for an intelligent database system.

Indexed as

Adverse Drug Reaction Reporting SystemsDrug LabelingUnited States Food and Drug AdministrationData MiningHumansMedication SystemsNatural Language ProcessingOhioUnited States

Identifiers

PMID23617267
PMCPMC3646673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.